The Economic Burden of Inflammatory Heart Disease in Korea.
10.4070/kcj.2011.41.12.712
- Author:
Seul Ki KO
1
;
Seok Jun YOON
;
In Hwan OH
;
Hye Young SEO
;
Eun Jung KIM
Author Information
1. School of Medicine, Korea University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Inflammation;
Cost of illness;
Endocarditis
- MeSH:
Cause of Death;
Cost of Illness;
Endocarditis;
Female;
Health Care Costs;
Heart;
Heart Diseases;
Humans;
Incidence;
Inflammation;
Inpatients;
Korea;
Male;
Mortality, Premature;
National Health Programs;
Outpatients;
Policy Making
- From:Korean Circulation Journal
2011;41(12):712-717
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND OBJECTIVES: The incidence of inflammatory heart diseases is not yet as high as those of other cardiovascular diseases; however, inflammatory heart diseases do have relatively high mortality rate. Therefore, update information on the economic burden of inflammatory heart diseases are necessary in order to appropriate policy making on these diseases. MATERIALS AND METHODS: This study used a number of resources to obtain data, national health insurance statistics, the Korean Health Panel, and the causes of death report by the Korean National Statistical Office. The total costs of inflammatory heart diseases were estimated as the sum of direct medical care costs, direct non-medical care and indirect costs. RESULTS: The total direct cost of inflammatory heart disease was higher in Korean men than that of Korean women and cost due to inpatient was higher than that of outpatients cost. The costs to cover premature death were highest among all of the components used to determine the total costs for inflammatory heart disease, representing 66.3% of these costs in Korea. CONCLUSION: Inflammatory heart disease has a relatively high mortality rate, and the costs that are associated with premature deaths consume the greatest proportion of the costs associated with this disease. In spite of some limitations of study, this could be a reliable evidence of economic burden of inflammatory heart disease.
